(Q38154918)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24151804%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Cytokines as biomarkers in depressive disorder: current standing and prospects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24151804%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24151804%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Frank Martin Schmidt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24151804%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Hubertus Himmerich

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24151804%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Robert Schumann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24151804%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Kenneth C Kirkby

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24151804%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

1 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24151804%20AND%20SRC:MED&resulttype=core&format=json

International Review of Psychiatry

28 February 2020

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24151804%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24151804%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24151804%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

592-603

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24151804%20AND%20SRC:MED&resulttype=core&format=json

Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Anorectic effects of circulating cytokines: role of the vascular blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

An open label trial of C-1073 (mifepristone) for psychotic major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Fluvoxamine treatment of major depression associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

The TNF-alpha system: functional aspects in depression, narcolepsy and psychopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Cytokines as modulators of the hypothalamus-pituitary-adrenal axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Cross-national epidemiology of DSM-IV major depressive episode

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Immune system to brain signaling: neuropsychopharmacological implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

The pro- and anti-inflammatory potential of interleukin-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Cognitive impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Depression and anxiety in a Portuguese MS population: associations with physical disability and severity of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Cytokine, sickness behavior, and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Connecting inflammation with glutamate agonism in suicidality.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

A prospective study of depression and immune dysregulation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Sustained elevation of serum interleukin-6 and relative insensitivity to hydrocortisone differentiates posttraumatic stress disorder with and without depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Erythropoietin induction by electroconvulsive seizure, gene regulation, and antidepressant-like behavioral effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

The Goldman Consensus statement on depression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Differential modulation of cytokine production in major depressive disorder by cortisol and dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

[The relevance of the TNF-alpha system in psychiatric disorders].

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Depression, comorbidities and the TNF-α system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

IFN-gamma reduction by tricyclic antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Regulatory T cells increased while IL-1β decreased during antidepressant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

TNF-alpha and ghrelin: opposite effects on immune system, metabolism and mental health

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Choice of treatment with antidepressants: influencing factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: A longitudinal study in patients treated with amitriptyline or paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Low CSF oxytocin reflects high intent in suicide attempters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Priming of peripheral monocytes with prolactin (PRL) sensitizes IFN-gamma-mediated indoleamine 2,3-dioxygenase (IDO) expression without affecting IFN-gamma signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Night work and inflammatory markers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Psychological Stress-Induced, IDO1-Dependent Tryptophan Catabolism: Implications on Immunosuppression in Mice and Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Antidepressant effects of TNF-α blockade in an animal model of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

The treatment of depressive states with G 22355 (imipramine hydrochloride).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Eicosanoid receptor subtype-mediated opposing regulation of TLR-stimulated expression of astrocyte glial-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

CSF biomarkers in suicide attempters--a principal component analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Dendritic cells and T cells in the regulation of cutaneous immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Inflammatory cytokines, growth factors, and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

The pro-inflammatory cytokine TNF-α regulates the activity and expression of the serotonin transporter (SERT) in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Proinflammatory and "resiliency" proteins in the CSF of patients with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Depression in multiple sclerosis as a function of length and severity of illness, age, remissions, and perceived social support

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Effects of escitalopram on stress-related relapses in women with multiple sclerosis: an open-label, randomized, controlled, one-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Treatment of depression for patients with multiple sclerosis in neurology clinics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Telephone-administered psychotherapy for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Effects of fluoxetine on disease activity in relapsing multiple sclerosis: a double-blind, placebo-controlled, exploratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Immunological aspects of depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Association of sickness absence with poor sleep and depressive symptoms in shift workers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson's disease and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Organic depression associated with flunarizine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Plasticity of T-cell phenotype and function: the T helper type 17 example.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Antidepressants for the treatment of depression in neurological disorders: a systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Regulation of the human serotonin transporter by interleukin-1 beta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Overnight changes of immune parameters and catecholamines are associated with mood and stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Serotonin transporter clustering in blood lymphocytes as a putative biomarker of therapeutic efficacy in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

The catecholamine hypothesis of affective disorders: a review of supporting evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Stress, depression and antidepressant treatment options in patients suffering from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Impact of fluoxetine on the human brain in multiple sclerosis as quantified by proton magnetic resonance spectroscopy and diffusion tensor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the Twins Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

An investigation into some psychiatric aspects of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Elevated cytokine expression in the orbitofrontal cortex of victims of suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Glatiramer acetate could be a potential antidepressant through its neuroprotective and anti-inflammatory effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Use of serotonergic antidepressants and bleeding risk in orthopedic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

How regulatory T cells work

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Bromocriptine and imipramine in endogenous depression. A double-blind controlled trial in out-patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442

Increase in Interleukin-1β in Late-Life Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09540261.2013.813442